{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T20:26:47Z","timestamp":1769718407986,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,8,23]],"date-time":"2009-08-23T00:00:00Z","timestamp":1250985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s00280-009-1108-4","type":"journal-article","created":{"date-parts":[[2009,8,22]],"date-time":"2009-08-22T04:14:00Z","timestamp":1250914440000},"page":"1029-1037","source":"Crossref","is-referenced-by-count":21,"title":["Beneficial effect of metronomic chemotherapy on tumor suppression and survival in a rat model of hepatocellular carcinoma with liver cirrhosis"],"prefix":"10.1007","volume":"65","author":[{"given":"Seong Tae","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Won","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gi Dae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joung Ah","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wonhee","family":"Hur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Young","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Dong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong Hyun","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan Ran","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si Hyun","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Kew","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,23]]},"reference":[{"key":"1108_CR1","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1038\/sj.onc.1206557","volume":"22","author":"TM Block","year":"2003","unstructured":"Block TM, Mehta AS, Fimmel CJ, Jordan R (2003) Molecular viral oncology of hepatocellular carcinoma. Oncogene 22:5093\u20135107","journal-title":"Oncogene"},{"key":"1108_CR2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/j.gastro.2004.09.039","volume":"127","author":"TJ Song","year":"2004","unstructured":"Song TJ, Ip EW, Fong Y (2004) Hepatocellular carcinoma: current surgical management. Gastroenterology 127:248\u2013260","journal-title":"Gastroenterology"},{"key":"1108_CR3","doi-asserted-by":"crossref","first-page":"12917","DOI":"10.1073\/pnas.2135406100","volume":"100","author":"G Bocci","year":"2003","unstructured":"Bocci G, Francia G, Man S, Lawler J, Kerbel RS (2003) Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy. Proc Natl Acad Sci USA 100:12917\u201312922","journal-title":"Proc Natl Acad Sci USA"},{"key":"1108_CR4","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1172\/JCI9872","volume":"105","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Bergers G, Bergsland E (2000) Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice. J Clin Invest 105:1045\u20131047","journal-title":"J Clin Invest"},{"key":"1108_CR5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrc1369","volume":"4","author":"RS Kerbel","year":"2004","unstructured":"Kerbel RS, Kamen BA (2004) The anti-angiogenic basis of metronomic chemotherapy. Nat Rev Cancer 4:423\u2013436","journal-title":"Nat Rev Cancer"},{"key":"1108_CR6","first-page":"1878","volume":"60","author":"T Browder","year":"2000","unstructured":"Browder T, Butterfield CE, Kraling BM, Shi B, Marshall B, O\u2019Reilly MS, Folkman J (2000) Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res 60:1878\u20131886","journal-title":"Cancer Res"},{"key":"1108_CR7","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S1470-2045(01)00587-3","volume":"2","author":"G Gasparini","year":"2001","unstructured":"Gasparini G (2001) Metronomic scheduling: the future of chemotherapy? Lancet Oncol 2:733\u2013740","journal-title":"Lancet Oncol"},{"key":"1108_CR8","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1080\/07357900600705599","volume":"24","author":"D Stempak","year":"2006","unstructured":"Stempak D, Seely D, Baruchel S (2006) Metronomic dosing of chemotherapy: applications in pediatric oncology. Cancer Invest 24:432\u2013443","journal-title":"Cancer Invest"},{"key":"1108_CR9","first-page":"261","volume":"9","author":"R Giavazzi","year":"1999","unstructured":"Giavazzi R, Taraboletti G (1999) Angiogenesis and angiogenesis inhibitors in cancer. Forum (Genova) 9:261\u2013272","journal-title":"Forum (Genova)"},{"key":"1108_CR10","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/386671a0","volume":"386","author":"W Risau","year":"1997","unstructured":"Risau W (1997) Mechanisms of angiogenesis. Nature 386:671\u2013674","journal-title":"Nature"},{"key":"1108_CR11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/scbi.1998.0091","volume":"9","author":"T Veikkola","year":"1999","unstructured":"Veikkola T, Alitalo K (1999) VEGFs, receptors and angiogenesis. Semin Cancer Biol 9:211\u2013220","journal-title":"Semin Cancer Biol"},{"key":"1108_CR12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/35025215","volume":"407","author":"GD Yancopoulos","year":"2000","unstructured":"Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J (2000) Vascular-specific growth factors and blood vessel formation. Nature 407:242\u2013248","journal-title":"Nature"},{"key":"1108_CR13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc1093","volume":"3","author":"G Bergers","year":"2003","unstructured":"Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3:401\u2013410","journal-title":"Nat Rev Cancer"},{"key":"1108_CR14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/74651","volume":"6","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet P (2000) Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389\u2013395","journal-title":"Nat Med"},{"key":"1108_CR15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","volume":"9","author":"N Ferrara","year":"2003","unstructured":"Ferrara N, Gerber HP, Le Couter J (2003) The biology of VEGF and its receptors. Nat Med 9:669\u2013676","journal-title":"Nat Med"},{"key":"1108_CR16","first-page":"4342","volume":"63","author":"F Bertolini","year":"2003","unstructured":"Bertolini F, Paul S, Mancuso P, Monestiroli S, Gobbi A, Shaked Y, Kerbel RS (2003) Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells. Cancer Res 63:4342\u20134346","journal-title":"Cancer Res"},{"key":"1108_CR17","first-page":"2731","volume":"62","author":"S Man","year":"2002","unstructured":"Man S, Bocci G, Francia G, Green SK, Jothy S, Hanahan D, Bohlen P, Hicklin DJ, Bergers G, Kerbel RS (2002) Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water. Cancer Res 62:2731\u20132735","journal-title":"Cancer Res"},{"key":"1108_CR18","doi-asserted-by":"crossref","first-page":"652","DOI":"10.5414\/CPP42652","volume":"42","author":"S Stolting","year":"2004","unstructured":"Stolting S, Klink T, Bela C, Engels C, Wagner T (2004) Metronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesis. Int J Clin Pharmacol Ther 42:652\u2013653","journal-title":"Int J Clin Pharmacol Ther"},{"key":"1108_CR19","first-page":"70","volume":"13","author":"TY Lee","year":"2007","unstructured":"Lee TY, Kim KT, Han SY (2007) Expression of ErbB receptor proteins and TGF-alpha during diethylnitrosamine-induced hepatocarcinogenesis in the rat liver. Korean J Hepatol 13:70\u201380","journal-title":"Korean J Hepatol"},{"key":"1108_CR20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.20538","volume":"41","author":"E Schiffer","year":"2005","unstructured":"Schiffer E, Housset C, Cacheux W, Wendum D, Desbois-Mouthon C, Rey C, Clergue F, Poupon R, Barbu V, Rosmorduc O (2005) Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis. Hepatology 41:307\u2013314","journal-title":"Hepatology"},{"key":"1108_CR21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1083\/jcb.119.3.493","volume":"119","author":"Y Gavrieli","year":"1992","unstructured":"Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493\u2013501","journal-title":"J Cell Biol"},{"key":"1108_CR22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/CAD.0b013e3282f2885f","volume":"19","author":"LP Pang","year":"2008","unstructured":"Pang LP, Huang W, Sun Q, Guo W, Li RT, Cui JR (2008) SLXM-2, a derivative of cyclophosphamide: mechanism of growth inhibition on hepatocarcinoma 22 cells. Anticancer Drugs 19:167\u2013174","journal-title":"Anticancer Drugs"},{"key":"1108_CR23","first-page":"1601","volume":"151","author":"G Lindner","year":"1997","unstructured":"Lindner G, Botchkarev VA, Botchkareva NV, Ling G, van der Veen C, Paus R (1997) Analysis of apoptosis during hair follicle regression (catagen). Am J Pathol 151:1601\u20131617","journal-title":"Am J Pathol"},{"key":"1108_CR24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/taap.1999.8849","volume":"162","author":"PE Mirkes","year":"2000","unstructured":"Mirkes PE, Little SA (2000) Cytochrome c release from mitochondria of early postimplantation murine embryos exposed to 4-hydroperoxycyclophosphamide, heat shock, and staurosporine. Toxicol Appl Pharmacol 162:197\u2013206","journal-title":"Toxicol Appl Pharmacol"},{"key":"1108_CR25","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1158\/0008-5472.CAN-05-0765","volume":"65","author":"Y Shaked","year":"2005","unstructured":"Shaked Y, Emmenegger U, Francia G, Chen L, Lee CR, Man S, Paraghamian A, Ben-David Y, Kerbel RS (2005) Low-dose metronomic combined with intermittent bolus-dose cyclophosphamide is an effective long-term chemotherapy treatment strategy. Cancer Res 65:7045\u20137051","journal-title":"Cancer Res"},{"key":"1108_CR26","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1200\/JCO.2001.19.4.1195","volume":"19","author":"KD Miller","year":"2001","unstructured":"Miller KD, Sweeney CJ, Sledge GW Jr (2001) Redefining the target: chemotherapeutics as antiangiogenics. J Clin Oncol 19:1195\u20131206","journal-title":"J Clin Oncol"},{"key":"1108_CR27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/emboj\/18.2.363","volume":"18","author":"M Meyer","year":"1999","unstructured":"Meyer M, Clauss M, Lepple-Wienhues A, Waltenberger J, Augustin HG, Ziche M, Lanz C, Buttner M, Rziha HJ, Dehio C (1999) A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO J 18:363\u2013374","journal-title":"EMBO J"},{"key":"1108_CR28","doi-asserted-by":"crossref","first-page":"16986","DOI":"10.1074\/jbc.M000528200","volume":"275","author":"N Rahimi","year":"2000","unstructured":"Rahimi N, Dayanir V, Lashkari K (2000) Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells. J Biol Chem 275:16986\u201316992","journal-title":"J Biol Chem"},{"key":"1108_CR29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/scbi.1998.0091","volume":"9","author":"T Veikkola","year":"1999","unstructured":"Veikkola T, Alitalo K (1999) VEGFs, receptors and angiogenesis. Semin Cancer Biol 9:211\u2013220","journal-title":"Semin Cancer Biol"},{"key":"1108_CR30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/path.1706","volume":"205","author":"DB Longley","year":"2005","unstructured":"Longley DB, Johnston PG (2005) Molecular mechanisms of drug resistance. J Pathol 205:275\u2013292","journal-title":"J Pathol"},{"key":"1108_CR31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjc.6604510","volume":"99","author":"S Raguz","year":"2008","unstructured":"Raguz S, Yague E (2008) Resistance to chemotherapy: new treatments and novel insights into an old problem. Br J Cancer 99:387\u2013391","journal-title":"Br J Cancer"},{"key":"1108_CR32","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/ijc.22688","volume":"121","author":"LJ Jia","year":"2007","unstructured":"Jia LJ, Wei DP, Sun QM, Jin GH, Li SF, Huang Y, Hua ZC (2007) Tumor-targeting Salmonella typhimurium improves cyclophosphamide chemotherapy at maximum tolerated dose and low-dose metronomic regimens in a murine melanoma model. Int J Cancer 121:666\u2013674","journal-title":"Int J Cancer"},{"key":"1108_CR33","first-page":"8408","volume":"63","author":"IF Hermans","year":"2003","unstructured":"Hermans IF, Chong TW, Palmowski MJ, Harris AL, Cerundolo V (2003) Synergistic effect of metronomic dosing of cyclophosphamide combined with specific antitumor immunotherapy in a murine melanoma model. Cancer Res 63:8408\u20138413","journal-title":"Cancer Res"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-009-1108-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-009-1108-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-009-1108-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T10:07:01Z","timestamp":1559038021000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-009-1108-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,23]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["1108"],"URL":"https:\/\/doi.org\/10.1007\/s00280-009-1108-4","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,23]]}}}